Myrica 50 Capsule

Indications

Management of neuropathic pain associated with diabetic peripheral neuropathy

Management of post-herpetic neuralgia

Adjunctive therapy for adult patients with partial-onset seizures

Management of fibromyalgia

Neuropathic pain associated with spinal cord injury.

Pharmacology

Pregabalin is a structural derivative of the inhibitory neurotransmitter gamma-aminobutyric acid (GABA). It does not bind directly to GABAA, GABAB, or benzodiazepine receptors. Pregabalin binds with high affinity to the alpha-2-delta site (an auxiliary subunit of voltage-gated calcium channels) in central nervous system tissues.

Dosage & Administration

In general, it is recommended that patients be started on a total daily dose no greater than 150 mg/day (75 mg two times a day, or 50 mg three times a day). Based on individual patient response and tolerability, the dose may be increased to a maximum dose of 600 mg/day.

Interaction

There are no significant interactions between Pregabalin with other antiepileptic drugs & oral contraceptives. Pregabalin may potentiate the effects of ethanol and lorazepam.

Contraindications

Pregabalin is contraindicated in patients with known hypersensitivity to pregabalin or any of its components.

Side Effects

The most common side effects include dizziness, somnolence, dry mouth, edema, blurred vision, weight gain, and abnormal thinking.

Pregnancy & Lactation

The pregnancy category of Pregabalin is C. So it should only be used if the potential benefit justifies the potential risks to the fetus.

Precautions & Warnings

Discontinuation of Pregabalin without tapering may produce insomnia, nausea, headache, and diarrhea. So it should be tapered gradually over a minimum of 1 week rather than discontinued abruptly.

Therapeutic Class

Adjunct anti-epileptic drugs.

Storage Conditions

Keep in a cool & dry place (below 30° C), protected from light & moisture. Keep out of the reach of children.

Pharmaceutical Name

UniMed UniHealth Pharmaceuticals Ltd